Simplified model for end-stage liver disease score predicts mortality for tricuspid valve surgery†
Authors:
Open Access
- 12 February 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 16 (5) , 630-635
Abstract
The model for end-stage liver disease score (MELD = 3.8*LN[total bilirubin] + 9.6*LN[creatinine] + 11.2*[PT-INR] + 6.4) predicts mortality for tricuspid valve surgery. However, the MELD is problematic in patients undergoing warfarin therapy, as warfarin affects the international normalized ratio (INR). This study aimed to determine whether a simplified MELD score that does not require the INR for calculation could predict mortality for patients undergoing tricuspid valve surgery. Simplified MELD A total of 172 patients (male: 66, female: 106; mean age, 63.8 ± 10.3 years) who underwent tricuspid replacement (n = 18) or repair (n = 154) from January 1991 to July 2011 at a single centre were included. Of them, 168 patients in whom the simplified MELD score could be calculated were retrospectively analysed. The relationship between in-hospital mortality and perioperative variables was assessed by univariate and multivariate analysis. The rate of in-hospital mortality was 6.4%. The mean admission simplified MELD score for the patients who died was significantly higher than for those surviving beyond discharge (11.3 ± 4.1 vs 5.8 ± 4.0; P = 0.001). By multivariate analysis, independent risk factors for in-hospital mortality included higher simplified MELD score (P = 0.001) and tricuspid valve replacement (P = 0.023). In-hospital mortality and morbidity increased along with increasing simplified MELD score. Scores 14 were associated with mortalities of 0, 2.0, 8.3 and 66.7%, respectively. The incidence of serious complications (multiple organ failure, P = 0.005; prolonged ventilation, P = 0.01; need for haemodialysis; P = 0.002) was also significantly higher in patients with simplified MELD score ≥7. The simplified MELD score predicts mortality in patients undergoing tricuspid valve surgery. This model requires only total bilirubin and creatinine and is therefore applicable in patients undergoing warfarin therapy.Keywords
This publication has 18 references indexed in Scilit:
- Retrospective cohort analysis of 926 tricuspid valve surgeries: Clinical and hemodynamic outcomes with propensity score analysisAmerican Heart Journal, 2012
- Surgical Risk and Outcome of Repair Versus Replacement for Late Tricuspid Regurgitation in Redo OperationThe Annals of Thoracic Surgery, 2012
- Thoracic and cardiovascular surgery in Japan during 2008General Thoracic and Cardiovascular Surgery, 2010
- The International Normalized Ratio (INR) in the MELD Score: Problems and SolutionsAmerican Journal of Transplantation, 2010
- Model for End-Stage Liver Disease Predicts Mortality for Tricuspid Valve SurgeryThe Annals of Thoracic Surgery, 2009
- Tricuspid valve surgery: a thirty-year assessment of early and late outcome☆European Journal of Cardio-Thoracic Surgery, 2008
- The international normalized ratio calibrated for cirrhosis (INRliver) normalizes prothrombin time results for model for end‐stage liver disease calculation†Hepatology, 2007
- The model for end-stage liver disease (MELD)Hepatology, 2007
- Clinical outcome after cardiac operations in patients with cirrhosisThe Annals of Thoracic Surgery, 2004
- Tricuspid valve surgery for functional tricuspid valve regurgitation associated with left-sided valvular diseaseEuropean Journal of Cardio-Thoracic Surgery, 2001